Evidence map›Paper›PMID 36386465›Full record

ReviewJournal of tissue engineering

Biofabrication of the osteochondral unit and its applications: Current and future directions for 3D bioprinting.

Patricia Santos-Beato, Swati Midha, Andrew A Pitsillides, Aline Miller, Ryo Torii, Deepak M Kalaskar

Abstract readReview
In one paragraph

Review in Journal of tissue engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. 3D-bioprinting for joint regeneration.Frontiers in bioengineering and biotechnology · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Challenges of engineering a functional growth plateFrontiers in bioengineering and biotechnology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Global hotspots and emerging trends in 3D bioprinting research.Frontiers in bioengineering and biotechnology · 2023
    Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patricia Santos-BeatoBiochemical Engineering Department, University College London, London, UK.
Swati MidhaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Andrew A PitsillidesComparative Biomedical Sciences, Royal Veterinary College, London, UK.
Aline MillerDepartment of Chemical Engineering, University of Manchester, Manchester, UK.
Ryo ToriiDepartment of Mechanical Engineering, University College London, London, UK.ORCID https://orcid.org/0000-0001-9479-8719
Deepak M KalaskarInstitute of Orthopaedics and Musculoskeletal Science, Division of Surgery & Interventional Science, University College London (UCL), UK.ORCID https://orcid.org/0000-0002-0576-1816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple prevalent diseases, such as osteoarthritis (OA), for which there is no cure or full understanding, affect the osteochondral unit; a complex interface tissue whose architecture, mechanical nature and physiological characteristics are still yet to be successfully reproduced in vitro. Although there have been multiple tissue engineering-based approaches to recapitulate the three dimensional (3D) structural complexity of the osteochondral unit, there are various aspects that still need to be improved. This review presents the different pre-requisites necessary to develop a human osteochondral unit construct and focuses on 3D bioprinting as a promising manufacturing technique. Examples of 3D bioprinted osteochondral tissues are reviewed, focusing on the most used bioinks, chosen cell types and growth factors. Further information regarding the applications of these 3D bioprinted tissues in the fields of disease modelling, drug testing and implantation is presented. Finally, special attention is given to the limitations that currently hold back these 3D bioprinted tissues from being used as models to investigate diseases such as OA. Information regarding improvements needed in bioink development, bioreactor use, vascularisation and inclusion of additional tissues to further complete an OA disease model, are presented. Overall, this review gives an overview of the evolution in 3D bioprinting of the osteochondral unit and its applications, as well as further illustrating limitations and improvements that could be performed explicitly for disease modelling.

Indexed as

Biofabricationbonecartilageosteochondral unit

Identifiers

PMID36386465
PMCPMC9643769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.